A Cost-Effectiveness Analysis of Interventions to Increase Repeat Testing in Patients Treated for Gonorrhea or Chlamydia at Public Sexually Transmitted Disease Clinics
- 1 September 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 32 (9) , 542-549
- https://doi.org/10.1097/01.olq.0000175414.80023.59
Abstract
Persons who have been infected with chlamydia or gonorrhea (CT/GC) are at elevated risk for reinfection. The cost-effectiveness of interventions designed to encourage public sexually transmitted disease (STD) clinic patients to return for rescreening has not been well-evaluated. The goal of this study was to conduct a program- and societal-perspective cost-effectiveness analysis of five interventions designed to encourage public STD clinic patients infected with CT/GC to return for rescreening 3 months after initial treatment. Researchers at two STD clinics collected cost data for the five interventions. These were combined with study data on return rates and CT/GC positivity rates among returning patients to compare the cost-effectiveness of the interventions. The cost per patient counseled with a brief recommendation to return, followed by a telephone reminder after 3 months, was higher than two interventions: a brief recommendation to return with no reminder and a $20 incentive, received on return. However, the brief recommendation with a telephone reminder yielded the highest return rate (33%) and was the least costly in terms of cost per infection treated ($622 program, $813 societal). In-depth motivational counseling that helped clients identify risk factors and provided reasons for returning was more costly than a phone reminder alone and was not more effective. Phone reminders are more cost-effective than motivational counseling and improve return rates over a brief recommendation given at the time of initial treatment.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of Methods to Increase Repeat Testing in Persons Treated for Gonorrhea and/or Chlamydia at Public Sexually Transmitted Disease ClinicsSexually Transmitted Diseases, 2004
- Asymptomatic sexually transmitted diseases: the case for screeningPreventive Medicine, 2003
- Patient-Delivered Partner Treatment With Azithromycin to Prevent Repeated Chlamydia trachomatis Infection Among WomenSexually Transmitted Diseases, 2003
- Multicenter Evaluation of the BDProbeTec ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral SwabsJournal of Clinical Microbiology, 2001
- Is the Routine Pelvic Examination Needed With the Advent of Urine-Based Screening for Sexually Transmitted Diseases?Archives of Pediatrics & Adolescent Medicine, 1999
- Screening Women for Chlamydia trachomatis in Family Planning ClinicsSexually Transmitted Diseases, 1998
- Treating Chlamydial Infection: Compliance Versus CostSexually Transmitted Diseases, 1998
- Cost of and Payment Source for Pelvic Inflammatory DiseaseJAMA, 1991
- The Incremental Cost of Screening, Diagnosis, and Treatment of Gonorrhea and Chlamydia in a Family Planning ClinicSexually Transmitted Diseases, 1989
- Chlamydia trachomatis Infections in the United StatesPublished by American Medical Association (AMA) ,1987